Emerging treatments in myopathies

被引:3
作者
Antozzi, C
Confalonieri, P
Mantegazza, R
DiDonato, S
机构
[1] NATL NEUROL INST C BESTA,DEPT BIOCHEM & GENET,I-20133 MILAN,ITALY
[2] NATL NEUROL INST C BESTA,NEUROMUSCULAR RES DEPT,I-20133 MILAN,ITALY
关键词
metabolic myopathies; inflammatory myopathies; muscular dystrophies; therapy;
D O I
10.1159/000113377
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Outstanding improvement has been made in the molecular understanding of several muscle diseases with the application of molecular biological techniques to the investigation of human disorders. The identification of genetic mutations has improved considerably the diagnostic approach to muscular dystrophies, mitochondrial myopathies and ion channel disorders. Important results have been achieved in the field of inflammatory myopathies, With a few exceptions, therapies available are nonspecific and rarely represent a cure for the disease. Molecular medicine offers an opportunity to design new therapeutic strategies based on the pathogenic mechanisms underlying each disease.
引用
收藏
页码:222 / 229
页数:8
相关论文
共 66 条
[1]
HUMAN DYSTROPHIN EXPRESSION IN MDX MICE AFTER INTRAMUSCULAR INJECTION OF DNA CONSTRUCTS [J].
ACSADI, G ;
DICKSON, G ;
LOVE, DR ;
JANI, A ;
WALSH, FS ;
GURUSINGHE, A ;
WOLFF, JA ;
DAVIES, KE .
NATURE, 1991, 352 (6338) :815-818
[2]
INCLUSION-BODY MYOSITIS - TREATMENT WITH INTRAVENOUS IMMUNOGLOBULIN [J].
AMATO, AA ;
BAROHN, RJ ;
JACKSON, CE ;
PAPPERT, EJ ;
SAHENK, Z ;
KISSEL, JT .
NEUROLOGY, 1994, 44 (08) :1516-1518
[3]
LATE-ONSET RIBOFLAVIN-RESPONSIVE MYOPATHY WITH COMBINED MULTIPLE ACYL-COENZYME-A DEHYDROGENASE AND RESPIRATORY-CHAIN DEFICIENCY [J].
ANTOZZI, C ;
GARAVAGLIA, B ;
MORA, M ;
RIMOLDI, M ;
MORANDI, L ;
URSINO, E ;
DIDONATO, S .
NEUROLOGY, 1994, 44 (11) :2153-2158
[4]
MONOCLONAL-ANTIBODY ANALYSIS OF MONONUCLEAR-CELLS IN MYOPATHIES .1. QUANTITATION OF SUBSETS ACCORDING TO DIAGNOSIS AND SITES OF ACCUMULATION AND DEMONSTRATION AND COUNTS OF MUSCLE-FIBERS INVADED BY T-CELLS [J].
ARAHATA, K ;
ENGEL, AG .
ANNALS OF NEUROLOGY, 1984, 16 (02) :193-208
[5]
TREATMENT OF MITOCHONDRIAL MYOPATHY DUE TO COMPLEX-III DEFICIENCY WITH VITAMINS K3 AND C - A P-31-NMR FOLLOW-UP-STUDY [J].
ARGOV, Z ;
BANK, WJ ;
MARIS, J ;
ELEFF, S ;
KENNAWAY, NG ;
OLSON, RE ;
CHANCE, B .
ANNALS OF NEUROLOGY, 1986, 19 (06) :598-602
[6]
Askanas Valerie, 1993, Current Opinion in Rheumatology, V5, P732
[7]
LIPOIC (THIOCTIC) ACID INCREASES BRAIN ENERGY AVAILABILITY AND SKELETAL-MUSCLE PERFORMANCE AS SHOWN BY IN-VIVO P-31-MRS IN A PATIENT WITH MITOCHONDRIAL CYTOPATHY [J].
BARBIROLI, B ;
MEDORI, R ;
TRITSCHLER, HJ ;
KLOPSTOCK, T ;
SEIBEL, P ;
REICHMANN, H ;
IOTTI, S ;
LODI, R ;
ZANIOL, P .
JOURNAL OF NEUROLOGY, 1995, 242 (07) :472-477
[8]
INCLUSION-BODY MYOSITIS - EXPLANATION FOR POOR RESPONSE TO IMMUNOSUPPRESSIVE THERAPY [J].
BAROHN, RJ ;
AMATO, AA ;
SAHENK, Z ;
KISSEL, JT ;
MENDELL, JR .
NEUROLOGY, 1995, 45 (07) :1302-1304
[9]
CONSTITUTIVE AND CYTOKINE-INDUCED PRODUCTION OF INTERLEUKIN-6 BY HUMAN MYOBLASTS [J].
BARTOCCIONI, E ;
MICHAELIS, D ;
HOHLFELD, R .
IMMUNOLOGY LETTERS, 1994, 42 (03) :135-138
[10]
P-31 NMR-SPECTROSCOPY AND ERGOMETER EXERCISE TEST AS EVIDENCE FOR MUSCLE OXIDATIVE PERFORMANCE IMPROVEMENT WITH COENZYME-Q IN MITOCHONDRIAL MYOPATHIES [J].
BENDAHAN, D ;
DESNUELLE, C ;
VANUXEM, D ;
CONFORTGOUNY, S ;
FIGARELLABRANGER, D ;
PELLISSIER, JF ;
KOZAKRIBBENS, G ;
POUGET, J ;
SERRATRICE, G ;
COZZONE, PJ .
NEUROLOGY, 1992, 42 (06) :1203-1208